TLX Telix Pharmaceuticals Limited
Healthcare$9.57+1.06%ClosedMarket Cap: $3.24B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$17.00
Target (Median)
$17.00
Target Range
$17.00 - $17.00
Upside from current price: 77.6%
Rating Distribution
0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-13 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-13 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-24 | Citigroup | maintain | Buy | Buy |
| 2026-01-21 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-23 | UBS | maintain | Buy | Buy |
| 2025-09-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-08-28 | Wedbush | maintain | Outperform | Outperform |
| 2025-08-28 | JP Morgan | downgrade | Neutral | Overweight |
| 2025-06-12 | Wedbush | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.17 | $1.65B | 4 |
| Sun Dec 31 | $0.50 | $1.96B | 8 |
| Mon Dec 31 | $0.66 | $1.98B | 6 |
| Tue Dec 31 | $1.09 | $2.40B | 6 |